Literature DB >> 10520677

How patients' preferences for risk information influence treatment choice in a case of high risk and high therapeutic uncertainty: asymptomatic localized prostate cancer.

D J Mazur1, D H Hickam, M D Mazur.   

Abstract

To assess how patients' preferences for non-numerical risk information are related to their tendency to choose early surgical treatment for asymptomatic gland-confined prostate cancer (a choice with high risk and high therapeutic uncertainty), the authors conducted a cross-sectional study of 228 patients receiving continuing care in a general medicine clinic. After being provided with three data disclosures related to the treatment decision, subjects were given a choice between surgery-now and watchful waiting. Data about surgical complications were presented in numerical format. The subjects were also asked whether they preferred communication with their physician about the chance (probability) of adverse outcomes-related to management strategies-in terms of words (such as possible or probable) or numbers (such as percentages). Of the 226 patients who chose either surgery-now or watchful waiting, 71.2% preferred risk information in terms of words only or numbers only: 44% words only, and 56% numbers only. Younger patients (OR = 1.06 per year; CI = 1.02-1.10, p = 0.0008) and those wanting risk communication in terms of words only (OR = 2.41; CI = 1.24-4.70, p = 0.01) tended to prefer surgery-now over watchful waiting as the management strategy for asymptomatic gland-confined prostate carcinoma. The authors conclude that there is a significant association between patients' preferences for risk communication with their physicians in terms of words only and a tendency to prefer early surgical intervention for prostate cancer when surgical risk data are provided numerically.

Entities:  

Mesh:

Year:  1999        PMID: 10520677     DOI: 10.1177/0272989X9901900407

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  11 in total

1.  Comprehension of the description of side effects in drug information leaflets: a survey of doctors, pharmacists and lawyers.

Authors:  Andreas Ziegler; Anka Hadlak; Steffi Mehlbeer; Inke R König
Journal:  Dtsch Arztebl Int       Date:  2013-10-04       Impact factor: 5.594

Review 2.  The extent of patients' understanding of the risk of treatments.

Authors:  A J Lloyd
Journal:  Qual Health Care       Date:  2001-09

Review 3.  Clinical implications of numeracy: theory and practice.

Authors:  Wendy Nelson; Valerie F Reyna; Angela Fagerlin; Isaac Lipkus; Ellen Peters
Journal:  Ann Behav Med       Date:  2008-08-02

4.  Risk communication in clinical trials: a cognitive experiment and a survey.

Authors:  Yin Bun Cheung; Hwee Lin Wee; Julian Thumboo; Cynthia Goh; Ricardo Pietrobon; Han Chong Toh; Yu Fen Yong; Say Beng Tan
Journal:  BMC Med Inform Decis Mak       Date:  2010-09-27       Impact factor: 2.796

5.  Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy.

Authors:  Al B Barqawi; Kevin J Krughoff; Khadijah Eid
Journal:  Adv Urol       Date:  2012-05-10

Review 6.  Factors that influence patient preferences for prostate cancer management options: A systematic review.

Authors:  Timothy N Showalter; Mark V Mishra; John Fp Bridges
Journal:  Patient Prefer Adherence       Date:  2015-07-02       Impact factor: 2.711

Review 7.  A systematic review of questionnaires about patient's values and preferences in clinical practice guidelines.

Authors:  Fei Bai; Juan Ling; Gloria Esoimeme; Liang Yao; Mingxia Wang; Jiajun Huang; Anchen Shi; Zehui Cao; Yaolong Chen; Jinhui Tian; Xiaoqin Wang; Kehu Yang
Journal:  Patient Prefer Adherence       Date:  2018-11-02       Impact factor: 2.711

8.  Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling.

Authors:  Caroline F Ockhuysen-Vermey; Lidewij Henneman; Christi J van Asperen; Jan C Oosterwijk; Fred H Menko; Daniëlle R M Timmermans
Journal:  BMC Cancer       Date:  2008-10-03       Impact factor: 4.430

9.  Discussing life expectancy with surgical patients: do patients want to know and how should this information be delivered?

Authors:  Michael G Clarke; Katherine P Kennedy; Ruaraidh P MacDonagh
Journal:  BMC Med Inform Decis Mak       Date:  2008-06-15       Impact factor: 2.796

10.  Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods.

Authors:  L F van de Water; J J van Kleef; W P M Dijksterhuis; I Henselmans; H G van den Boorn; N M Vaarzon Morel; K F Schut; J G Daams; E M A Smets; H W M van Laarhoven
Journal:  Qual Life Res       Date:  2020-04-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.